243 related articles for article (PubMed ID: 19581908)
1. Controversies in the treatment of idiopathic membranous nephropathy.
Waldman M; Austin HA
Nat Rev Nephrol; 2009 Aug; 5(8):469-79. PubMed ID: 19581908
[TBL] [Abstract][Full Text] [Related]
2. Corticosteroids and ciclosporin A in idiopathic membranous nephropathy: higher remission rates of nephrotic syndrome and less adverse reactions than after traditional treatment with cytotoxic drugs.
Goumenos DS; Katopodis KP; Passadakis P; Vardaki E; Liakopoulos V; Dafnis E; Stefanidis I; Vargemezis V; Vlachojannis JG; Siamopoulos KC
Am J Nephrol; 2007; 27(3):226-31. PubMed ID: 17389782
[TBL] [Abstract][Full Text] [Related]
3. Synthetic ACTH in High Risk Patients with Idiopathic Membranous Nephropathy: A Prospective, Open Label Cohort Study.
van de Logt AE; Beerenhout CH; Brink HS; van de Kerkhof JJ; Wetzels JF; Hofstra JM
PLoS One; 2015; 10(11):e0142033. PubMed ID: 26562836
[TBL] [Abstract][Full Text] [Related]
4. The remission of nephrotic syndrome with cyclosporin treatment does not attenuate the progression of idiopathic membranous nephropathy.
Goumenos DS; Kalliakmani P; Tsakas S; Sotsiou F; Vlachojannis JG
Clin Nephrol; 2004 Jan; 61(1):17-24. PubMed ID: 14964453
[TBL] [Abstract][Full Text] [Related]
5. Immunosuppressive treatment for nephrotic idiopathic membranous nephropathy: a meta-analysis based on Chinese adults.
Xie G; Xu J; Ye C; Chen D; Xu C; Yang L; Ma Y; Hu X; Li L; Sun L; Zhao X; Mao Z; Mei C
PLoS One; 2012; 7(9):e44330. PubMed ID: 22957065
[TBL] [Abstract][Full Text] [Related]
6. Tacrolimus combined with corticosteroids versus Modified Ponticelli regimen in treatment of idiopathic membranous nephropathy: Randomized control trial.
Ramachandran R; Hn HK; Kumar V; Nada R; Yadav AK; Goyal A; Kumar V; Rathi M; Jha V; Gupta KL; Sakhuja V; Kohli HS
Nephrology (Carlton); 2016 Feb; 21(2):139-46. PubMed ID: 26205759
[TBL] [Abstract][Full Text] [Related]
7. Predictors of response and relapse in patients with idiopathic membranous nephropathy treated with tacrolimus.
Caro J; Gutiérrez-Solís E; Rojas-Rivera J; Agraz I; Ramos N; Rabasco C; Espinosa M; Valera A; Martín M; Frutos MÁ; Perea L; Juárez GF; Ocaña J; Arroyo D; Goicoechea M; Fernández L; Oliet A; Hernández Y; Romera A; Segarra A; Praga M;
Nephrol Dial Transplant; 2015 Mar; 30(3):467-74. PubMed ID: 25274748
[TBL] [Abstract][Full Text] [Related]
8. Overview of current and alternative therapies for idiopathic membranous nephropathy.
Tran TH; J Hughes G; Greenfeld C; Pham JT
Pharmacotherapy; 2015 Apr; 35(4):396-411. PubMed ID: 25884528
[TBL] [Abstract][Full Text] [Related]
9. The Effect of Mycophenolate Mofetil versus Cyclosporine as Combination Therapy with Low Dose Corticosteroids in High-risk Patients with Idiopathic Membranous Nephropathy: a Multicenter Randomized Trial.
Choi JY; Kim DK; Kim YW; Yoo TH; Lee JP; Chung HC; Cho KH; An WS; Lee DH; Jung HY; Cho JH; Kim CD; Kim YL; Park SH
J Korean Med Sci; 2018 Feb; 33(9):e74. PubMed ID: 29441742
[TBL] [Abstract][Full Text] [Related]
10. Cyclophosphamide or chlorambucil therapy is indicated in idiopathic membranous nephropathy with strong risk factors for progression.
Hebert LA; Rovin BH; Agarwal AK; Spetie DN
Am J Kidney Dis; 2005 Apr; 45(4):788-9; author replyy 789-90. PubMed ID: 15806488
[No Abstract] [Full Text] [Related]
11. Outcome of idiopathic membranous nephropathy using targeted stepwise immunosuppressive treatment strategy.
Aaltonen S; Honkanen E
Nephrol Dial Transplant; 2011 Sep; 26(9):2871-7. PubMed ID: 21427071
[TBL] [Abstract][Full Text] [Related]
12. Membranous nephropathy: when and how to treat.
Lai KN
Kidney Int; 2007 May; 71(9):841-3. PubMed ID: 17457329
[TBL] [Abstract][Full Text] [Related]
13. Idiopathic membranous nephropathy: diagnosis and treatment.
Fervenza FC; Sethi S; Specks U
Clin J Am Soc Nephrol; 2008 May; 3(3):905-19. PubMed ID: 18235148
[TBL] [Abstract][Full Text] [Related]
14. The efficacy and safety of tacrolimus monotherapy in adult-onset nephrotic syndrome caused by idiopathic membranous nephropathy.
Liang Q; Li H; Xie X; Qu F; Li X; Chen J
Ren Fail; 2017 Nov; 39(1):512-518. PubMed ID: 28562168
[TBL] [Abstract][Full Text] [Related]
15. [Steroid and cyclosporine therapy in idiopathic membranous nephropathy: monocentric experience and literature review].
Zotta F; Di Stasio E; Manzione A; Pirozzi N; Stoppacciaro A; Menè P
G Ital Nefrol; 2019 Jun; 36(3):. PubMed ID: 31251003
[TBL] [Abstract][Full Text] [Related]
16. Association of diabetes with failure to achieve complete remission of idiopathic membranous nephropathy.
Xie H; Li C; Wen Y; Ye W; Cai J; Li H; Li X; Li X
Int Urol Nephrol; 2020 Feb; 52(2):337-342. PubMed ID: 31820359
[TBL] [Abstract][Full Text] [Related]
17. Out of Africa: Complete and partial remissions as a combined outcome in patients with idiopathic membranous glomerulonephritis in Cape Town.
Ameh OI; Swanepoel CR; Aderibigbe A; Kengne AP; Okpechi IG
Nephrology (Carlton); 2016 Dec; 21(12):1010-1016. PubMed ID: 26706191
[TBL] [Abstract][Full Text] [Related]
18. [Membranous nephropathy: New insights in therapeutic approach].
Dahan K
Nephrol Ther; 2017 Apr; 13 Suppl 1():S83-S87. PubMed ID: 28577748
[TBL] [Abstract][Full Text] [Related]
19. Improving long-term outcomes in idiopathic membranous nephropathy using a distinctive cyclosporine regimen.
Hassan K; Kristal B
Minerva Urol Nefrol; 2016 Jun; 68(3):293-301. PubMed ID: 25645342
[TBL] [Abstract][Full Text] [Related]
20. An overview of immunosuppressive therapy in idiopathic membranous nephropathy.
Maas R; Hofstra JM; Wetzels JF
Minerva Med; 2012 Aug; 103(4):253-66. PubMed ID: 22805618
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
